Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Nature of the Business - Narrative (Details)

v3.21.1
Nature of the Business - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
PCR testing, amount recorded, COVID-19 $ 6,061 $ 0  
PCR testing, write-offs, COVID-19 5,300    
PCR testing, general and administrative expenses, COVID-19 800    
COVID-19, deferred social security payroll tax   $ 5,900 $ 5,900
Employee Retention Tax Credit, COVID-19 $ 400